AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Solana Co Director's Dealing 2022

May 25, 2022

32724_dirs_2022-05-25_71330dc0-c79e-480b-b577-2c055efd9d3d.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: HELIUS MEDICAL TECHNOLOGIES, INC. (HSDT)
CIK: 0001610853
Period of Report: 2022-05-23

Reporting Person: MATHIESEN JEFFREY S (N/A)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2022-05-23	Stock Option (Right to Buy)	$4.68	A	37000	Acquired	2032-05-22	Common Stock (37000)	Direct

Footnotes

F1: Grant to the Reporting Person of a stock option to purchase 37,000 shares of common stock under the Issuer's 2022 Equity Incentive Plan. Vests as to 6,170 shares on June 30, 2022, with the remainder vesting in 10 equal amounts on the last day of each fiscal quarter thereafter.